In addition, CD24 was observed in the cytoplasm and membrane in common clinical classifications of cancer, such as follicular adenoma carcinoma and papillary adenocarcinoma (THCA); seminoma and embryonal carcinoma (TGCT); duct carcinoma and lobular carcinoma (BRCA); and cystadenocarcinoma, serous carcinoma, and endometrial carcinoma (OV) (Figure 4D). This evidence concerns the gene CD24 and invasive breast carcinoma.